Key facts
- eBioSpine’s last known valuation is $3.1M (Aug 2025).
- It has raised $680K; the latest was Seed Round ($680K) in Aug 2025.
- Notable investors include Incubate Fund, Startup Hokkaido.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for eBioSpine
- ·The full record, as it builds
Funding rounds
No funding rounds for eBioSpine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About eBioSpine
Manufacturer of medical devices intended to related to spinal cord diseases. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Japan
- Founded
- 2023
- Employees
- 10
- Ownership
- Privately Held (backing)
eBioSpine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in eBioSpine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on eBioSpine in its N-PORT filings yet. We sweep new filings monthly.